PARAGON: A phase 2 study of anastrozole (An) in patients with estrogen receptor(ER) and / progesterone receptor (PR) positive recurrent/metastatic granulosa cell tumors/sex-cord stromal tumors (GCT) of the ovary

被引：4

作者：

Banerjee, Susana N.

Tang, Monica

O'Connell, Rachel

Clamp, Andrew R.

Lord, Rosemary

Mullassery, Vinod Menon

Hall, Marcia

Gourley, Charlie

Bonaventura, Tony

Goh, Jeffrey C.

Sykes, Peter

Grant, Peter T.

McNally, Orla

Edmondson, Richard J.

Friedlander, Michael

机构：

[1] Royal Marsden NHS Fdn Trust, London, England

[2] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia

[3] Christie NHS Fdn Trust, Manchester, Lancs, England

[4] Univ Manchester, Manchester, Lancs, England

[5] NCRI, Wirral, Merseyside, England

[6] Clatterbridge Canc Ctr NHS Fdn Trust, Wirral, Merseyside, England

[7] Guys & St Thomas NHS Fdn Trust, London, England

[8] Mt Vernon Canc Ctr, Northwood, Middx, England

[9] Univ Edinburgh, Canc Res UK Ctr, MRC IGMM, Edinburgh, Midlothian, Scotland

[10] Calvary Mater Hosp, Newcastle, NSW, Australia

[11] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia

[12] Christchurch Womens Hosp, Christchurch, New Zealand

[13] Mercy Hosp Women, Heidelberg, Vic, Australia

[14] Royal Womens Hosp, Melbourne, Vic, Australia

[15] St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England

[16] Prince Wales Hosp, Randwick, NSW, Australia

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.5524

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5524

引用

页数：2